The SEC Is Too Lax on CEO Health Disclosure

Company shareholders have a right to know when an executive's life hangs in the balance. As things now stand, Securities & Exchange Commission rules are exceedingly vague about what a company should disclose about the health of a C-level official, and how soon that disclosure should be made.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.